Healthcare - Sector
Cortexyme's activity chart (see below) currently has 19 price targets and 23 ratings on display.
Analysts' price targets on this stock were met 77.5% of the time, taking 162.25 days on average.
Most recent stock forecast was given by from MORGAN STANLEY on 11-May-2022. First documented stock forecast 03-Jun-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 26-Apr-2021
$3.5
$14
4 years 6 months 10 days ago
(11-May-2022)
1/2 (50%)
$0.36 (11.46%)
184
Buy Since 03-Jun-2019
4 years 7 months 16 days ago
(05-Apr-2022)
1/2 (50%)
$61.49 (455.14%)
15
Buy Since 24-Jun-2020
$15
$30
4 years 8 months 12 days ago
(09-Mar-2022)
2/5 (40%)
$10.18 (211.20%)
293
Hold Since 27-Jan-2022
$53
4 years 9 months 25 days ago
(27-Jan-2022)
1/1 (100%)
$28.87 (119.64%)
200
Sell Since 11-Dec-2020
$5
5 years 10 days ago
(11-Nov-2021)
3/3 (100%)
$-8.51 (-62.99%)
155
What is CRTX (Cortexyme) average time for price targets to be met?
Which analyst most recently updated their price target on CRTX (Cortexyme)?
Which analyst has the most public recommendations on CRTX (Cortexyme)?
Which analyst is the currently most bullish on CRTX (Cortexyme)?
Which analyst is the currently most reserved on CRTX (Cortexyme)?